Latent transforming growth factor beta binding protein 4: A regulator of mitochondrial function in acute kidney injury
Aging Cell · 2023
DOI: 10.1111/acel.14019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging Cell, 2023. Verfasst von Kit Neikirk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Recently, latent transforming growth factor beta binding protein 4 (LTBP4) was implicated in the pathogenesis of renal damage through its modulation of mitochondrial dynamics. The seminal article written by Su et al. entitled “LTBP4 (Latent Transforming Growth Factor Beta Binding Protein 4) Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts” uncovers LTBP4's renoprotective role against acute kidney injury via modulating mitochondrial dynamics. Recently, LTBP4 has emerged as a driver in the mitochondrial‐dependent modulation of age‐related organ pathologies. This article aims to expand our understanding of LTBP4's diverse roles in these diseases in the context of these recent findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.
- Department of Neuroscience, Cell Biology and Physiology, Wright State University, Dayton, Ohio, USA.
- Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
- Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania, USA.
ORCID-Profile: Antentor Hinton
Förderung
- NIDDK NIH HHS
- NIH HHS
- NHLBI NIH HHS
- Burroughs Wellcome Fund
- Chan Zuckerberg Initiative
- National Institutes of Health
- Bristol-Myers Squibb
- Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center
Zitieren
APA
Neikirk, K., Ume, A. C., Prasad, P., Marshall, A. G., Rockwood, J., Wenegieme, T. Y., McMichael, K. E., McReynolds, M. R., Williams, C. R., & Hinton, A. (2023). Latent transforming growth factor beta binding protein 4: A regulator of mitochondrial function in acute kidney injury. Aging Cell. https://doi.org/10.1111/acel.14019
Vancouver
Neikirk K, Ume AC, Prasad P, Marshall AG, Rockwood J, Wenegieme TY, et al. Latent transforming growth factor beta binding protein 4: A regulator of mitochondrial function in acute kidney injury. Aging Cell. 2023. doi:10.1111/acel.14019
BibTeX
@article{Neikirk2023,
author = {Neikirk, Kit and Ume, Adaku C and Prasad, Praveena and Marshall, Andrea G and Rockwood, Jananie and Wenegieme, Tara-Yesomi and McMichael, Kelia E and McReynolds, Melanie R and Williams, Clintoria R and Hinton, Antentor},
title = {Latent transforming growth factor beta binding protein 4: A regulator of mitochondrial function in acute kidney injury},
journal = {Aging Cell},
year = {2023},
doi = {10.1111/acel.14019}
}
EUVIMED